Celbarin Capsule

About Celbarin 200 mg Capsule

Celbarin 200 mg capsule is an antiviral medicine containing ribavirin, used in combination with other drugs to treat chronic hepatitis C in adults with compensated liver disease. It is not used alone.

There are 5 brands of Ribavirin listed in Bangladesh. By unit price, Celbarin is among the cheapest of them.

What is Celbarin 200 mg Capsule?

Celbarin 200 mg capsule contains ribavirin, a synthetic nucleoside antiviral. It is used in combination with other antiviral drugs to treat chronic hepatitis C virus infection in adults with compensated liver disease, including those not previously treated with interferon and those coinfected with HIV. Ribavirin should not be used alone. The exact way it works is not fully understood, but it interferes with viral nucleic acid synthesis. Treatment duration and combination are decided by the doctor. Ribavirin can cause serious side effects, including birth defects, and is contraindicated in pregnancy.

Uses of Celbarin

Celbarin is used for chronic hepatitis C in adults, always with other antiviral medicines. It is for patients with compensated liver disease who have not had interferon alpha before, and for adults with hepatitis C and HIV coinfection. It is not for use as a single medicine. The doctor decides the combination and course.

How to use Celbarin

Take Celbarin exactly as your doctor prescribes. Swallow the capsule whole with water; do not crush or chew. The dose and duration depend on your condition, other medicines, and response to treatment. Do not start, stop, or change the dose without your doctor's advice. If you miss a dose, ask your doctor or pharmacist what to do. Keep out of reach of children.

Side effects of Celbarin

Common side effects with combination therapy include psychiatric and central nervous system effects, severe eye disorders, dental and periodontal problems, and growth inhibition in children and adolescents that may be irreversible in some. Other side effects can occur. Tell your doctor if you notice any unusual symptoms, especially mood changes, vision problems, or dental issues. Do not self-treat.

Safety and precautions

Celbarin is contraindicated in pregnancy and in women who may become pregnant, because ribavirin can cause fetal harm. Both men and women must use effective contraception during treatment and for months after, as advised by the doctor. A negative pregnancy test is required before starting. Do not use in patients with hemoglobinopathies such as thalassemia major or sickle-cell anemia, or with didanosine. It is not known if ribavirin passes into breast milk, so breastfeeding should be discussed with the doctor. Ask your doctor before use if you have liver, kidney, or blood problems.

Frequently asked questions

What is the price of Celbarin 200 mg capsule?

The listed price is ৳ 35.00. For the exact current price and availability, please check with your pharmacy or the website.

Is Celbarin safe during pregnancy or breastfeeding?

No, Celbarin is contraindicated in pregnancy because it can harm the fetus. Effective contraception is required for both men and women during and after treatment. It is not known if it passes into breast milk, so breastfeeding is not recommended unless your doctor advises otherwise.

What is Celbarin used for and what kind of medicine is it?

Celbarin contains ribavirin, an antiviral medicine. It is used in combination with other antiviral drugs to treat chronic hepatitis C in adults with compensated liver disease. It is not used alone. Your doctor will decide the appropriate combination therapy.

What does the dosage form and strength mean?

Celbarin comes as a capsule, which is a solid dosage form to be swallowed whole. The strength is 200 mg of ribavirin per capsule. The doctor will determine how many capsules you need and for how long, based on your condition.

Indications

Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with other antiviral drugs in patients with compensated liver disease not previously treated with interferon alpha and in adult CHC patients coinfected with HIV. Ribavirin should not be used alone.

Pharmacology

Ribavirin is a synthetic nucleoside which has inhibitory action against respiratory syncytial virus, influenza virus and herpes simplex virus. The mechanism of action is not clear. It may act at several sites including cellular enzymes to interfere with viral nucleic acid synthesis. The mono- and triphosphate derivatives are known to be responsible for the antiviral action of the compound.

Dosage & Administration

The recommended duration of treatment for patients previously untreated with interferon is 24 to 48 weeks. After 24 weeks of treatment virologic response should be assessed. Treatment discontinuation should be considered in any patient who has not achieved an HCV RNA below the limit of detection of the assay by 24 weeks. There are no safety and efficacy data on treatment for longer than 48 weeks in the previously untreated patient population. In patients who relapse following interferon therapy, the recommended duration of treatment is 24 weeks. There are no safety and efficacy data on treatment for longer than 24 weeks in the relapse patient populations.

Ribavirin + Interferon: Genotype Ribavirin Daily Interferon alpha-2a Duration or interferon alpha-2b.
  • All <75 kg: (400+600) mg 3 MIU 3 times weekly 48 weeks Genotypes subcutaneously (Genotype1&4)
  • >75 kg: (600+600) mg 24 weeks (Genotype2&3)
Ribavirin + Peg-Interferon: Genotype Ribavirin Daily Peg-Interferon alpha-2a Duration or Peg-interferon alpha-2b:
  • 1 & 4 < 75 kg: (400+600) mg 180 gm once weekly 48 weeks
  • > 75 kg: (600+600) mg subcutaneously 2 & 3 (400+400) mg 24 weeks
Ribavirin may be administered without regard to food, but should be administered in a consistent manner. Drink plenty of water while being treated with this medication; drinking water will decrease the risk of serious side effects.

Interaction

Nucleoside reverse transcriptase inhibitors or reduce dose or discontinue interferon, ribavirin or both with worsening toxicities

Azathioprine: Concomitant use of azathioprine with ribavirin has been reported to induce severe pancytopenia and may increase the risk of azathioprine-related myelotoxicity.

Contraindications

Women who are pregnant. Ribavirin may cause fetal harm when administered to a pregnant woman. Ribavirin is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Patients with hemoglobinopathies (e.g., thalassemia major or sickle-cell anemia). In combination with didanosine. Reports of fatal hepatic failure, as well as peripheral neuropathy, pancreatitis and symptomatic hyperlactatemia/lactic acidosis have been reported in clinical trials.

Side Effects

The most common adverse reactions in adults receiving combination therapy are psychiatric and central nervous system effects, severe ocular disorder, dental and periodontal disorders & growth inhibition in children and adolescents that may be irreversible in some patients. The most common adverse reactions in pediatric subjects were similar to those seen in adults.

Pregnancy & Lactation

Pregnancy Category X. Ribavirin produced significant embryocidal and/or teratogenic effects in all animal species in which adequate studies have been conducted. Malformations of the skull, palate, eye, jaw, limbs, skeleton and gastrointestinal tract were noted. The incidence and severity of teratogenic effects increased with escalation of the drug dose. Survival of fetuses and offspring was reduced.

Nursing Mothers: It is not known whether Ribavirin is excreted in human milk. Because many drugs are excreted in human milk and to avoid any potential for serious adverse reactions in nursing infants from ribavirin, a decision should be made either to discontinue nursing or therapy with Ribavirin, based on the importance of the therapy to the mother.

Precautions & Warnings

Birth defects and fetal death with ribavirin: Do not use in pregnancy and for 6 months after treatment. Patients must have a negative pregnancy test prior to therapy, use at least 2 forms of contraception and undergo monthly pregnancy tests. For a male patient, it is very important for his female partner to avoid becoming pregnant during treatment and during the 7 months after treatment and do not have sex with a pregnant women.

Storage Conditions

Keep out of the reach of children. Keep in a cool & dry place. Protect from light.

Alternative brands of Ribavirin

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.